| SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes AC Ferreira, VC Soares, IG de Azevedo-Quintanilha, SSG Dias, ... Cell death discovery 7 (1), 43, 2021 | 243 | 2021 |
| Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators SSG Dias, VC Soares, AC Ferreira, CQ Sacramento, ... PLoS pathogens 16 (12), e1009127, 2020 | 237 | 2020 |
| Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and proinflammatory cytokine production N Fintelman-Rodrigues, CQ Sacramento, C Ribeiro Lima, ... Antimicrobial agents and chemotherapy 64 (10), 10.1128/aac. 00825-20, 2020 | 182 | 2020 |
| In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19 CQ Sacramento, N Fintelman-Rodrigues, JR Temerozo, APD Da Silva, ... Journal of Antimicrobial Chemotherapy 76 (7), 1874-1885, 2021 | 67 | 2021 |
| Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture X Wang, CQ Sacramento, S Jockusch, OA Chaves, C Tao, ... Communications Biology 5 (1), 154, 2022 | 54 | 2022 |
| SARS-CoV-2 proteins bind to hemoglobin and its metabolites GC Lechuga, F Souza-Silva, CQ Sacramento, MRO Trugilho, RH Valente, ... International Journal of Molecular Sciences 22 (16), 9035, 2021 | 50 | 2021 |
| Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives FC Santos, P Abreu, HC Castro, ICPP Paixão, CC Cirne-Santos, ... Bioorganic & medicinal chemistry 17 (15), 5476-5481, 2009 | 46 | 2009 |
| Protective effect of gedunin on TLR-mediated inflammation by modulation of inflammasome activation and cytokine production: evidence of a multitarget compound PV Borges, KH Moret, NM Raghavendra, TEM Costa, AP Monteiro, ... Pharmacological research 115, 65-77, 2017 | 42 | 2017 |
| Platelet-monocyte interaction amplifies thromboinflammation through tissue factor signaling in COVID-19 ED Hottz, R Martins-Gonçalves, L Palhinha, IG Azevedo-Quintanilha, ... Blood Advances 6 (17), 5085-5099, 2022 | 37 | 2022 |
| Simvastatin downregulates the SARS-CoV-2-induced inflammatory response and impairs viral infection through disruption of lipid rafts L Teixeira, JR Temerozo, FS Pereira-Dutra, AC Ferreira, M Mattos, ... Frontiers in Immunology 13, 820131, 2022 | 37 | 2022 |
| The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2 CQ Sacramento, N Fintelman-Rodrigues, JR Temerozo, ... BioRxiv, 2020.06. 15.153411, 2020 | 35 | 2020 |
| Neutrophil extracellular trap-enriched supernatants carry microRNAs able to modulate TNF-α production by macrophages L Linhares-Lacerda, JR Temerozo, M Ribeiro-Alves, EP Azevedo, ... Scientific Reports 10 (1), 2715, 2020 | 32 | 2020 |
| Commercially available flavonols are better SARS-CoV-2 inhibitors than isoflavone and flavones OA Chaves, N Fintelman-Rodrigues, X Wang, CQ Sacramento, ... Viruses 14 (7), 1458, 2022 | 31 | 2022 |
| Macrophage resistance to HIV-1 infection is enhanced by the neuropeptides VIP and PACAP JR Temerozo, R Joaquim, EG Regis, W Savino, DC Bou-Habib PloS one 8 (6), e67701, 2013 | 31 | 2013 |
| VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells JR Temerozo, CQ Sacramento, N Fintelman-Rodrigues, CRR Pão, ... Journal of Leukocyte Biology 111 (5), 1107-1121, 2022 | 30* | 2022 |
| Neuroendocrine control of macrophage development and function AD Jurberg, V Cotta-de-Almeida, JR Temerozo, W Savino, DC Bou-Habib, ... Frontiers in Immunology 9, 369488, 2018 | 29 | 2018 |
| Activation of Toll-like receptor 2 increases macrophage resistance to HIV-1 infection S Victoria, JR Temerozo, L Gobbo, HK Pimenta-Inada, DC Bou-Habib Immunobiology 218 (12), 1529-1536, 2013 | 27 | 2013 |
| Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology JR Temerozo, N Fintelman-Rodrigues, MC Dos Santos, ED Hottz, ... Microbiome 10 (1), 65, 2022 | 26 | 2022 |
| A biosafety level 2 mouse model for studying betacoronavirus-induced acute lung damage and systemic manifestations ACSP Andrade, GH Campolina-Silva, CM Queiroz-Junior, LC de Oliveira, ... Journal of virology 95 (22), 10.1128/jvi. 01276-21, 2021 | 26 | 2021 |
| Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo OA Chaves, CQ Sacramento, AC Ferreira, M Mattos, ... Pharmaceuticals 15 (1), 21, 2021 | 25 | 2021 |
Thiago Moreno L. SouzaFiocruzVerified email at cdts.fiocruz.br
